Inhibition of ovarian cancer metastasis by adeno-associated virus-mediated gene transfer of nm23H1 in an orthotopic implantation model

J. Li, J. Zhou, G. Chen, H. Wang, S. Wang, H. Xing, Q. Gao, Y. Lu, Y. He, D. Ma

Research output: Contribution to journalArticle

31 Citations (Scopus)

Abstract

Ovarian cancer is one of the most threatening malignant tumors in females due to the frequent occurrence of metastasis that precedes diagnosis. The present study explored the possibility of preventing ovarian cancer metastasis by promoting nm23H1 expression through adeno-associated virus (AAV)-mediated gene transfer. A cell line of high metastatic potential, SW626-M4, was derived by in vivo selection and used to establish an ovarian cancer metastasis model in the mouse. Liver metastasis and animal survival time were measured after transfer of a recombinant adeno-associated viral vector expressing nm23H1 (AAV-nm23H1) into the aforementioned model. Intraperitoneal injection of AAV-nm23H1 into this orthotopic implantation model of ovarian cancer resulted in (1) expression of the exogenous gene in more than 95% of tumor cells in situ in nude mice; (2) a 60% reduction in the number of animals developing liver metastases; and (3) a 35-day prolongation of median survival time compared with the untreated host group. In conclusion, the results support the feasibility of induction of nm23H1 expression through gene transfer as a therapeutic strategy for preventing metastases and prolonging host survival time, and indicate that AAV vectors deserve attention in the design of future gene therapy approaches to achieving long-term expression of curative genes in vivo.

Original languageEnglish (US)
Pages (from-to)266-272
Number of pages7
JournalCancer Gene Therapy
Volume13
Issue number3
DOIs
StatePublished - Mar 2006

Fingerprint

Dependovirus
Ovarian Neoplasms
Neoplasm Metastasis
Genes
Gene Expression
Liver
Intraperitoneal Injections
Nude Mice
Genetic Therapy
Neoplasms
Cell Line

Keywords

  • Adeno-associated virus (AAV)
  • Metastasis
  • nm23H1
  • Ovarian cancer

ASJC Scopus subject areas

  • Cancer Research
  • Genetics

Cite this

Inhibition of ovarian cancer metastasis by adeno-associated virus-mediated gene transfer of nm23H1 in an orthotopic implantation model. / Li, J.; Zhou, J.; Chen, G.; Wang, H.; Wang, S.; Xing, H.; Gao, Q.; Lu, Y.; He, Y.; Ma, D.

In: Cancer Gene Therapy, Vol. 13, No. 3, 03.2006, p. 266-272.

Research output: Contribution to journalArticle

Li, J. ; Zhou, J. ; Chen, G. ; Wang, H. ; Wang, S. ; Xing, H. ; Gao, Q. ; Lu, Y. ; He, Y. ; Ma, D. / Inhibition of ovarian cancer metastasis by adeno-associated virus-mediated gene transfer of nm23H1 in an orthotopic implantation model. In: Cancer Gene Therapy. 2006 ; Vol. 13, No. 3. pp. 266-272.
@article{af7d5698d36446ea98381cc2cc3eedff,
title = "Inhibition of ovarian cancer metastasis by adeno-associated virus-mediated gene transfer of nm23H1 in an orthotopic implantation model",
abstract = "Ovarian cancer is one of the most threatening malignant tumors in females due to the frequent occurrence of metastasis that precedes diagnosis. The present study explored the possibility of preventing ovarian cancer metastasis by promoting nm23H1 expression through adeno-associated virus (AAV)-mediated gene transfer. A cell line of high metastatic potential, SW626-M4, was derived by in vivo selection and used to establish an ovarian cancer metastasis model in the mouse. Liver metastasis and animal survival time were measured after transfer of a recombinant adeno-associated viral vector expressing nm23H1 (AAV-nm23H1) into the aforementioned model. Intraperitoneal injection of AAV-nm23H1 into this orthotopic implantation model of ovarian cancer resulted in (1) expression of the exogenous gene in more than 95{\%} of tumor cells in situ in nude mice; (2) a 60{\%} reduction in the number of animals developing liver metastases; and (3) a 35-day prolongation of median survival time compared with the untreated host group. In conclusion, the results support the feasibility of induction of nm23H1 expression through gene transfer as a therapeutic strategy for preventing metastases and prolonging host survival time, and indicate that AAV vectors deserve attention in the design of future gene therapy approaches to achieving long-term expression of curative genes in vivo.",
keywords = "Adeno-associated virus (AAV), Metastasis, nm23H1, Ovarian cancer",
author = "J. Li and J. Zhou and G. Chen and H. Wang and S. Wang and H. Xing and Q. Gao and Y. Lu and Y. He and D. Ma",
year = "2006",
month = "3",
doi = "10.1038/sj.cgt.7700899",
language = "English (US)",
volume = "13",
pages = "266--272",
journal = "Cancer Gene Therapy",
issn = "0929-1903",
publisher = "Nature Publishing Group",
number = "3",

}

TY - JOUR

T1 - Inhibition of ovarian cancer metastasis by adeno-associated virus-mediated gene transfer of nm23H1 in an orthotopic implantation model

AU - Li, J.

AU - Zhou, J.

AU - Chen, G.

AU - Wang, H.

AU - Wang, S.

AU - Xing, H.

AU - Gao, Q.

AU - Lu, Y.

AU - He, Y.

AU - Ma, D.

PY - 2006/3

Y1 - 2006/3

N2 - Ovarian cancer is one of the most threatening malignant tumors in females due to the frequent occurrence of metastasis that precedes diagnosis. The present study explored the possibility of preventing ovarian cancer metastasis by promoting nm23H1 expression through adeno-associated virus (AAV)-mediated gene transfer. A cell line of high metastatic potential, SW626-M4, was derived by in vivo selection and used to establish an ovarian cancer metastasis model in the mouse. Liver metastasis and animal survival time were measured after transfer of a recombinant adeno-associated viral vector expressing nm23H1 (AAV-nm23H1) into the aforementioned model. Intraperitoneal injection of AAV-nm23H1 into this orthotopic implantation model of ovarian cancer resulted in (1) expression of the exogenous gene in more than 95% of tumor cells in situ in nude mice; (2) a 60% reduction in the number of animals developing liver metastases; and (3) a 35-day prolongation of median survival time compared with the untreated host group. In conclusion, the results support the feasibility of induction of nm23H1 expression through gene transfer as a therapeutic strategy for preventing metastases and prolonging host survival time, and indicate that AAV vectors deserve attention in the design of future gene therapy approaches to achieving long-term expression of curative genes in vivo.

AB - Ovarian cancer is one of the most threatening malignant tumors in females due to the frequent occurrence of metastasis that precedes diagnosis. The present study explored the possibility of preventing ovarian cancer metastasis by promoting nm23H1 expression through adeno-associated virus (AAV)-mediated gene transfer. A cell line of high metastatic potential, SW626-M4, was derived by in vivo selection and used to establish an ovarian cancer metastasis model in the mouse. Liver metastasis and animal survival time were measured after transfer of a recombinant adeno-associated viral vector expressing nm23H1 (AAV-nm23H1) into the aforementioned model. Intraperitoneal injection of AAV-nm23H1 into this orthotopic implantation model of ovarian cancer resulted in (1) expression of the exogenous gene in more than 95% of tumor cells in situ in nude mice; (2) a 60% reduction in the number of animals developing liver metastases; and (3) a 35-day prolongation of median survival time compared with the untreated host group. In conclusion, the results support the feasibility of induction of nm23H1 expression through gene transfer as a therapeutic strategy for preventing metastases and prolonging host survival time, and indicate that AAV vectors deserve attention in the design of future gene therapy approaches to achieving long-term expression of curative genes in vivo.

KW - Adeno-associated virus (AAV)

KW - Metastasis

KW - nm23H1

KW - Ovarian cancer

UR - http://www.scopus.com/inward/record.url?scp=32844471517&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=32844471517&partnerID=8YFLogxK

U2 - 10.1038/sj.cgt.7700899

DO - 10.1038/sj.cgt.7700899

M3 - Article

C2 - 16179930

AN - SCOPUS:32844471517

VL - 13

SP - 266

EP - 272

JO - Cancer Gene Therapy

JF - Cancer Gene Therapy

SN - 0929-1903

IS - 3

ER -